TSX open
Loading markets…

Advertisement

Stocks

Why Diagnos Inc stock is rising today

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:ADK.V

Get ADK alerts:

Photos provided by Pexels

Diagnos Inc is seeing a notable rise in its stock price, reflecting positive market sentiment.

Diagnos Inc (ADK.V) is up today, gaining 3.64% in value as it trades at CA$0.28. This increase comes amid a generally cautious market, highlighting investor interest in the company’s potential.

Advertisement

KOHO

Earn cash back with a smarter spending account

Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.

Diagnos Inc

ADK.V

Full stock page →

ADK.V

Diagnos Inc

Source:WealthAwesomeWealthAwesome
$0.02 (-8.33%)
120 day period
$0.18$0.25$0.32Feb 4May 5Jul 30

Market cap

$34.32M

52W high

$0.42

52W low

$0.18

1W change

+19.57%

Beta

-0.16

Analyst Price Targets

Based on analyst covering ADK

📈

Wall Street analysts forecast ADK stock price to rise 445.5% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$1.50

+445.5% Upside

Current Price

C$0.28

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on ADK's historical volatility

HistoricalForecast68%95%
C$0.12C$0.27C$0.43C$0.58C$0.74C$0.89TodayMar 23May 27Jul 30Sep 11Oct 25Dec 7

30-Day Vol

80.8%

Annualized

90-Day Vol

63.7%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$0.33

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.29C$0.22C$0.39
60 trading daysC$0.31C$0.21C$0.46
90 trading daysC$0.33C$0.20C$0.53

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Investor takeaway: While the stock's rise is encouraging, investors should stay cautious due to the company's small market cap and limited coverage.

3.64% Increase in Stock Price

Diagnos Inc's stock has risen by 3.64% today, indicating growing interest from investors despite its small market size.

Bull case

The recent changes to convertible debentures may indicate that Diagnos Inc is becoming more financially flexible, which could improve its growth prospects.

Bear case

With a market cap of just CA$33 million, Diagnos Inc remains a speculative investment, and its stock price can be quite volatile.

Stock Performance Overview

Advertisement

Diagnos Inc's stock has shown a positive trend today, climbing 3.64% to a trading price of CA$0.28. This increase is particularly noteworthy given the company's small market cap of CA$33 million, which can often lead to heightened volatility in stock prices.

Recent Company Developments

While there have been no recent announcements directly impacting the stock today, the company's previous changes to convertible debentures could be contributing to the current investor optimism. These financial moves may suggest a strategic approach to managing capital and future growth.

Market Sentiment and Future Outlook

Despite the positive movement in Diagnos Inc's stock, investors should approach with caution. The limited coverage and small-cap nature of the company mean that any fluctuations can be pronounced. It's essential to keep an eye on broader market trends and company developments that could affect future performance.


Advertisement

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: July 31, 2026
Last Updated: July 31, 2026

Sponsored links

Advertisement